Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2013

Duma Energy Corp. (DUMA) Continues Mapping Massive Namibia Concession, Sees Deeper Horizon Potential in Galveston Bay

Duma Energy, the oil and gas production firm with a solid domestic footprint of interests in Illinois and Texas (both onshore and offshore in Galveston Bay), has been making significant progress at their Owambo Basin assets over in northern Namibia … Continue reading

Posted in Small Cap News | Leave a comment

SpendSmart Payments Company (SSPC) Sponsoring Meet & Greet Sweepstakes for Justin Bieber Concerts

Today, payment solutions provider SpendSmart Payments Company announced that it is launching a Meet & Greet Sweepstakes promotion for Justin Bieber’s 2013 summer “Believe” tour. Anyone who signs up for a SpendSmart Prepaid Card through July 21st will be entered … Continue reading

Posted in Small Cap News | Leave a comment

PITOOEY!, Inc. (PTOO) Business Solutions Follow Shifting Digital Advertising Trends

PITOOEY! is an Internet marketing company using its proprietary technology to assist companies in establishing and developing an online presence. The company also provides these companies with an array of products and services designed to enhance communication between them and … Continue reading

Posted in PITOOEY! Inc. PTOO | Leave a comment

Velti Plc (VELT) Partners with Virgin Unite to Launch Mobile Donation Platform for the Nelson Mandela Appeal

Leading global mobile marketing and advertising technology provider Velti has partnered with Virgin Unite, the nonprofit foundation of the Virgin Group, to launch mobile messaging donations for the Nelson Mandela Appeal. This marks a milestone for the nonprofit foundation, as … Continue reading

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Raises $4.0M in Preferred Stock Financing

Cardium Therapeutics has completed the second tranche of its previously announced registered direct offering consisting of an additional 1,656 shares of Series A convertible preferred stock for gross proceeds of approximately $1.7 million, bringing the total gross proceeds of the … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Digital Cinema Destinations Corp. (DCIN) to Feature on RedChip Money Report, Fox Business News

Bud Mayo, CEO and chairman of Digital Cinema, a U.S. motion picture exhibitor focused on transforming movie theaters into digital entertainment centers, is slated to appear on The RedChip Money Report™ tonight at 10 p.m. PT (July 19 at 1 … Continue reading

Posted in Digital Cinema Destinations Corp. DCIN | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) to Address U.S. Pharmaceutical “Crisis” with Innovative Stem Cell-based Technology

Since its inception in 1998, the U.S. National Institutes of Health (NIH) has awarded biotech small-cap VistaGen Therapeutics with $11.3 million in R&D grants, including $2.3 million to support the company’s development of its Human Clinical Trials in a Test … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

HeartWare International (HTWR) Sees Global Opportunity, Application for HeartWare® Ventricular Assist System

Medical device company HeartWare International develops and manufactures miniaturized implantable heart pumps called ventricular assist devices (VADs) to treat patients with advanced heart failure, providing a less invasive scale compared to traditional treatments. Approximately 1 million patients suffer from the … Continue reading

Posted in Small Cap News | Leave a comment

Medistem, Inc. (MEDS) Files Form 10 to Re-enter Public Capital Markets, Backed by Development Progress

Medistem, a clinical-stage company developing a universal stem cell product derived from the endometrium, Monday filed a Form 10 registration statement with the Securities and Exchange Commission, wrapping up a voluntary four-year cessation from fully reporting in order to focus … Continue reading

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Effects 1-for-20 Reverse Split

Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, announced a 1-for-20 reverse split of the company’s issued and outstanding common stock, effective today at market open, reducing the number of issued and outstanding common shares to approximately 6.5 … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment